GLP-1 drugs could cut mortality rates in US and UK, Swiss Re says
Reinsurance News - Sep 18, 2025
Swiss Re, a reinsurance company based in Zurich, has released new research suggesting that GLP-1 weight-loss medications could substantially reduce mortality rates in the United States and the United Kingdom over the next two decades. According to the company’s projections, if these drugs are widely...
Recommended Articles
Posted: Apr 01, 2026
In a letter to shareholders accompanying AIG’s annual report, chairman and CEO Peter Zaffino emphasi...
Posted: Apr 01, 2026
AM Specialty Insurance Group (ASIG), a provider of specialty insurance solutions, has announced a se...
Posted: Apr 01, 2026
Acrisure, a global fintech leader, has completed its previously announced acquisition of specialty r...